MedCity News

AUGUST 9, 2024

The White House might soon finalize a rule that will either save or cost patients billions of dollars in prescription drug costs. The rule concerns “copay accumulators,” which are programs health plans use to prevent copay assistance from counting toward patients’ deductibles or out-of-pocket maximums. The post An Upcoming White House Decision May Jeopardize Americans’ Access to Life-Saving Drugs appeared first on MedCity News.

Prescription 331

Prescription Patients Biopharma 331

Fierce Pharma

AUGUST 9, 2024

Legend Biotech CEO Ying Huang, Ph.D., already had a lot on his plate when speculations of a potential geopolitical crackdown and the option of a buyout emerged. | Legend Biotech CEO Ying Huang, Ph.D., already had a lot on his plate when speculations of a potential geopolitical crackdown and the option of a buyout emerged.

306

306

MedCity News

AUGUST 9, 2024

Through a new partnership, Eleanor Health’s patients can access Thriveworks’ therapists for additional mental health support beyond their substance-use disorder, including couples and family counseling. Likewise, Thriveworks’ patients in Louisiana, Massachusetts, New Jersey, North Carolina, Ohio, Texas and Washington can receive substance-use disorder treatment from Eleanor Health.

Patients 289

Patients 289

Fierce Pharma

AUGUST 9, 2024

With Gilead's stated focus to grow in oncology, the company's recent quarterly updates have placed a heavy emphasis on its developments in the cancer space. | The HIV-focused drugmaker looks to position its long-acting Sunlenca as a prime PrEP option after the med aced a phase 3 study.

Marketing 293

Marketing 293

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

MedCity News

AUGUST 9, 2024

Business and compliance considerations for MSOs and PCs, the contractual structure, and general recommendations for establishing a model that runs efficiently and mitigates levels of risk The post “Friendly” PC Models: Key Contractual and Compliance Considerations appeared first on MedCity News.

Physicians 289

Physicians 289

Fierce Pharma

AUGUST 9, 2024

As Purdue Pharma attempts to restore its image following its role in | As Purdue Pharma attempts to restore its image following its role in the U.S. opioid crisis, the Connecticut-based company has scored a win with a green light for a new overdose rescue treatment.

Pharma 284

Pharma FDA 284

PharmaVoice

AUGUST 9, 2024

Here’s what the leaders of the companies with the 10 drugs in the first wave of price negotiations with Medicare said about how the new prices will impact their portfolio.

Pharma 228

Pharma 228

MedCity News

AUGUST 9, 2024

This latest eBook highlights the content of our conferences — INVEST in Chicago and INVEST Digital Health in Dallas. It spotlights talks such as Small business Education and Entrepreneurial Development funding, investor perspectives on AI, women’s health, health tech implementation, medtech trends, cybersecurity, and drug development innovation.

Education 264

Education 264

pharmaphorum

AUGUST 9, 2024

Eli Lilly's oral tau drug fails to show efficacy in a phase 2 trial in Alzheimer's disease in another setback for the class

124

124

PharmaTimes

AUGUST 9, 2024

The study revealed that 13% of patients have a genetic form of the neurological disease

Patients 119

Patients 119

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

pharmaphorum

AUGUST 9, 2024

Eli Lilly raises guidance for 2024 by $3 billion on strong growth for tirzepatide in diabetes and obesity and improved supply capacity

117

117

PharmaTimes

AUGUST 9, 2024

In the UK, there are an estimated 11 million people living with a neurological condition

119

119

pharmaphorum

AUGUST 9, 2024

At the second attempt, the FDA has approved Citius Pharmaceuticals' Lymphir for rare lymphoma CTCL

FDA 111

FDA Pharmaceutical 111

Pharma IQ

AUGUST 9, 2024

Discover how AI and patient-on-chip technology are revolutionising drug discovery and development.

Patients 100

Patients 100

Advertiser: ZoomInfo

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

Marketing

Pharmaceutical Technology

AUGUST 9, 2024

Days after competitor Novo Nordisk posted underwhelming Wegovy sales, Eli Lilly cited “strong performance” for Zepbound and Mounjaro.

Sales 98

Sales 98

pharmaphorum

AUGUST 9, 2024

Another TIGIT trial failure has been abandoned, casting a shadow once again over the target as a cancer immunotherapy strategy.The latest setback is in a phase 3 trial of MSD's anti-TIGIT antibody vibostolimab and PD-1 inhibitor pembrolizumab in small cell lung cancer (SCLC), with a lack of efficacy and side effects both contributing to the decision.

Side effects 89

Side effects 89

Pharmaceutical Technology

AUGUST 9, 2024

In the past few years, there has been a significant increase in the use of GLP-1 receptor agonists as a treatment for Type 2 diabetes and obesity.

Marketing 72

Marketing 72

Pharmaceutical Commerce

AUGUST 9, 2024

Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.

Pharma 64

Pharma Healthcare Healthcare 64

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

pharmaphorum

AUGUST 9, 2024

MSD abandons another phase 3 TIGIT inhibitor trial, in another setback for the beleaguered cancer immunotherapy class

64

64

Pharmacy Times

AUGUST 9, 2024

neffy is an epinephrine nasal spray for the emergency treatment of allergic reactions in adults and pediatric patients.

FDA 64

FDA Patients 64

European Pharmaceutical Review

AUGUST 9, 2024

Clinical data indicates that nipocalimab could provide benefit to foetuses, newborns and pregnant mothers at risk for a rare blood disorder. Findings from the Phase II UNITY study show that the treatment has potential to delay or prevent anaemia and the need for intrauterine blood transfusions in babies who are at high risk for haemolytic disease of the foetus and newborn (HDFN).

Medicine 52

Medicine Leads Medical Pharmaceutical 52

Pharmacy Times

AUGUST 9, 2024

Statins and non-statin cholesterol-lowering agents show potential in reducing the risk of liver cancer.

58

58

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

Pharmaceutical Technology

AUGUST 9, 2024

For an upfront payment of $700m, MSD will gain access to the CD3 and CD19-targeting bispecific antibody CN201.

Marketing 52

Marketing 52

Pharmacy Times

AUGUST 9, 2024

Pharmacy is at a fork in the road.

55

55

PharmaTech

AUGUST 9, 2024

AGX101 targets the cancer cells and vasculature of a tumor, and works to eliminate the tumor blood vessels, kill tumor cells capable of invasion or metastasis, and direct the immune system to attack the cancer.

52

52

Pharmacy Times

AUGUST 9, 2024

Previously, an independent advisory panel for the FDA rejected the use of MDMA-assisted therapy for posttraumatic stress disorder (PTSD), citing concerns of the reliability of the clinical trial data.

FDA 55

FDA 55

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Pharmaceutical Commerce

AUGUST 9, 2024

Why the integration of AI-enabled solutions has the potential to boost patient support and engagement across numerous patient care settings.

Patients 52

Patients 52

Pharmacy Times

AUGUST 9, 2024

A variety of signs and symptoms of lymphoma were reported, including fever, stomach discomfort, and weight loss.

Patients 52

Patients 52

PharmExec

AUGUST 9, 2024

As part of the acquisition of CN201, Curon is expected to receive an upfront payment of $700 million, with the opportunity to earn an additional $600 million in milestone payments linked to the drug's development and regulatory approval.

52

52

Pharmacy Times

AUGUST 9, 2024

The study is expected to include 460 individuals that will be randomly treated with 12mg of ifinatamab deruxtecan or chemotherapy chosen by the health care provider.

52

52

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy